Titre : Australasie

Australasie : Questions médicales fréquentes

{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Australasie : Questions médicales les plus fréquentes", "headline": "Australasie : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Australasie : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-04-22", "dateModified": "2025-04-17", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Australasie" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Océanie", "url": "https://questionsmedicales.fr/mesh/D044349", "about": { "@type": "MedicalCondition", "name": "Océanie", "code": { "@type": "MedicalCode", "code": "D044349", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "Z01.678" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Australie", "alternateName": "Australia", "url": "https://questionsmedicales.fr/mesh/D001315", "about": { "@type": "MedicalCondition", "name": "Australie", "code": { "@type": "MedicalCode", "code": "D001315", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "Z01.678.100.373" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Territoire de la capitale australienne", "alternateName": "Australian Capital Territory", "url": "https://questionsmedicales.fr/mesh/D020958", "about": { "@type": "MedicalCondition", "name": "Territoire de la capitale australienne", "code": { "@type": "MedicalCode", "code": "D020958", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "Z01.678.100.373.500" } } }, { "@type": "MedicalWebPage", "name": "Nouvelle-Galles du Sud", "alternateName": "New South Wales", "url": "https://questionsmedicales.fr/mesh/D009517", "about": { "@type": "MedicalCondition", "name": "Nouvelle-Galles du Sud", "code": { "@type": "MedicalCode", "code": "D009517", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "Z01.678.100.373.750" } } }, { "@type": "MedicalWebPage", "name": "Territoire du Nord", "alternateName": "Northern Territory", "url": "https://questionsmedicales.fr/mesh/D015876", "about": { "@type": "MedicalCondition", "name": "Territoire du Nord", "code": { "@type": "MedicalCode", "code": "D015876", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "Z01.678.100.373.875" } } }, { "@type": "MedicalWebPage", "name": "Queensland", "alternateName": "Queensland", "url": "https://questionsmedicales.fr/mesh/D011793", "about": { "@type": "MedicalCondition", "name": "Queensland", "code": { "@type": "MedicalCode", "code": "D011793", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "Z01.678.100.373.937" } } }, { "@type": "MedicalWebPage", "name": "Australie-Méridionale", "alternateName": "South Australia", "url": "https://questionsmedicales.fr/mesh/D013021", "about": { "@type": "MedicalCondition", "name": "Australie-Méridionale", "code": { "@type": "MedicalCode", "code": "D013021", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "Z01.678.100.373.968" } } }, { "@type": "MedicalWebPage", "name": "Tasmanie", "alternateName": "Tasmania", "url": "https://questionsmedicales.fr/mesh/D013648", "about": { "@type": "MedicalCondition", "name": "Tasmanie", "code": { "@type": "MedicalCode", "code": "D013648", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "Z01.678.100.373.984" } } }, { "@type": "MedicalWebPage", "name": "Victoria", "alternateName": "Victoria", "url": "https://questionsmedicales.fr/mesh/D014739", "about": { "@type": "MedicalCondition", "name": "Victoria", "code": { "@type": "MedicalCode", "code": "D014739", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "Z01.678.100.373.992" } } }, { "@type": "MedicalWebPage", "name": "Australie occidentale", "alternateName": "Western Australia", "url": "https://questionsmedicales.fr/mesh/D014904", "about": { "@type": "MedicalCondition", "name": "Australie occidentale", "code": { "@type": "MedicalCode", "code": "D014904", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "Z01.678.100.373.996" } } } ] }, { "@type": "MedicalWebPage", "name": "Nouvelle-Zélande", "alternateName": "New Zealand", "url": "https://questionsmedicales.fr/mesh/D009520", "about": { "@type": "MedicalCondition", "name": "Nouvelle-Zélande", "code": { "@type": "MedicalCode", "code": "D009520", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "Z01.678.100.747" } } }, { "@type": "MedicalWebPage", "name": "Iles du Pacifique", "alternateName": "Pacific Islands", "url": "https://questionsmedicales.fr/mesh/D010139", "about": { "@type": "MedicalCondition", "name": "Iles du Pacifique", "code": { "@type": "MedicalCode", "code": "D010139", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "Z01.678.100.873" } } } ], "about": { "@type": "MedicalCondition", "name": "Australasie", "alternateName": "Australasia", "code": { "@type": "MedicalCode", "code": "D044362", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "None None", "url": "https://questionsmedicales.fr/author/None%20None", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "Ainsley J Newson", "url": "https://questionsmedicales.fr/author/Ainsley%20J%20Newson", "affiliation": { "@type": "Organization", "name": "Faculty of Medicine and Health, Sydney School of Public Health, Sydney Health Ethics, The University of Sydney, Sydney, NSW, Australia." } }, { "@type": "Person", "name": "Thomas Beaney", "url": "https://questionsmedicales.fr/author/Thomas%20Beaney", "affiliation": { "@type": "Organization", "name": "Imperial Clinical Trials Unit, Imperial College London, Stadium House, 68 Wood Lane, London, UK." } }, { "@type": "Person", "name": "Xin Xia", "url": "https://questionsmedicales.fr/author/Xin%20Xia", "affiliation": { "@type": "Organization", "name": "Imperial Clinical Trials Unit, Imperial College London, Stadium House, 68 Wood Lane, London, UK." } }, { "@type": "Person", "name": "Neil R Poulter", "url": "https://questionsmedicales.fr/author/Neil%20R%20Poulter", "affiliation": { "@type": "Organization", "name": "Imperial Clinical Trials Unit, Imperial College London, Stadium House, 68 Wood Lane, London, UK." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "IBD barriers across the continents: a continent-specific analysis - Australasia.", "datePublished": "2023-09-08", "url": "https://questionsmedicales.fr/article/37701793", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1177/17562848231197509" } }, { "@type": "ScholarlyArticle", "name": "Contraceptive access and use among women with migratory experience living in high-income countries: a scoping review.", "datePublished": "2024-09-20", "url": "https://questionsmedicales.fr/article/39304878", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12889-024-19778-y" } }, { "@type": "ScholarlyArticle", "name": "Global burden of pelvic inflammatory disease and ectopic pregnancy from 1990 to 2019.", "datePublished": "2023-10-02", "url": "https://questionsmedicales.fr/article/37784046", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12889-023-16663-y" } }, { "@type": "ScholarlyArticle", "name": "Pollination crisis Down-Under: Has Australasia dodged the bullet?", "datePublished": "2023-10-30", "url": "https://questionsmedicales.fr/article/37915803", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/ece3.10639" } }, { "@type": "ScholarlyArticle", "name": "Activities critical to success and growth of clinical trials networks. What is needed and how are we doing? An Australian and New Zealand perspective.", "datePublished": "2023-11-04", "url": "https://questionsmedicales.fr/article/37925441", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s13063-023-07709-y" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Régions géographiques", "item": "https://questionsmedicales.fr/mesh/D005842" }, { "@type": "ListItem", "position": 3, "name": "Océanie", "item": "https://questionsmedicales.fr/mesh/D044349" }, { "@type": "ListItem", "position": 4, "name": "Australasie", "item": "https://questionsmedicales.fr/mesh/D044362" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Australasie - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Australasie", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-03", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Australasie", "description": "Comment diagnostiquer une maladie tropicale en Australasie ?\nQuels tests sont utilisés pour le paludisme en Australasie ?\nComment identifier une infection par le virus Zika ?\nQuels sont les signes d'une infection à leptospirose ?\nComment diagnostiquer une maladie de Lyme en Australasie ?", "url": "https://questionsmedicales.fr/mesh/D044362?page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Australasie", "description": "Quels sont les symptômes du chikungunya ?\nComment se manifeste la dengue ?\nQuels signes indiquent une infection par le virus de l'herpès ?\nQuels symptômes d'une intoxication alimentaire ?\nComment reconnaître une infection respiratoire ?", "url": "https://questionsmedicales.fr/mesh/D044362?page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Australasie", "description": "Comment prévenir la dengue en Australasie ?\nQuelles mesures pour éviter le chikungunya ?\nComment se protéger contre le virus Zika ?\nQuelles sont les recommandations pour la leptospirose ?\nComment prévenir les infections respiratoires ?", "url": "https://questionsmedicales.fr/mesh/D044362?page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Australasie", "description": "Quels traitements pour la dengue ?\nComment traiter une infection par le virus Zika ?\nQuels médicaments pour le chikungunya ?\nComment traiter une infection à leptospirose ?\nQuels sont les traitements pour la maladie de Lyme ?", "url": "https://questionsmedicales.fr/mesh/D044362?page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Australasie", "description": "Quelles complications peuvent survenir avec la dengue ?\nQuels risques associés au chikungunya ?\nQuelles complications de l'infection par le virus Zika ?\nQuelles complications de la leptospirose ?\nQuels risques de la maladie de Lyme non traitée ?", "url": "https://questionsmedicales.fr/mesh/D044362?page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Australasie", "description": "Quels sont les facteurs de risque pour la dengue ?\nQui est à risque pour le chikungunya ?\nQuels facteurs augmentent le risque de virus Zika ?\nQuels sont les risques associés à la leptospirose ?\nQui est à risque pour la maladie de Lyme ?", "url": "https://questionsmedicales.fr/mesh/D044362?page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une maladie tropicale en Australasie ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Un diagnostic repose sur l'historique médical, les symptômes et des tests de laboratoire." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour le paludisme en Australasie ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les tests de diagnostic incluent les frottis sanguins et les tests de dépistage rapide." } }, { "@type": "Question", "name": "Comment identifier une infection par le virus Zika ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "L'infection est confirmée par des tests sanguins spécifiques et l'historique de voyage." } }, { "@type": "Question", "name": "Quels sont les signes d'une infection à leptospirose ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent fièvre, douleurs musculaires et éruption cutanée, nécessitant des tests." } }, { "@type": "Question", "name": "Comment diagnostiquer une maladie de Lyme en Australasie ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur l'exposition aux tiques et des tests sérologiques spécifiques." } }, { "@type": "Question", "name": "Quels sont les symptômes du chikungunya ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent fièvre, douleurs articulaires et éruptions cutanées." } }, { "@type": "Question", "name": "Comment se manifeste la dengue ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "La dengue se manifeste par une forte fièvre, des douleurs corporelles et des éruptions cutanées." } }, { "@type": "Question", "name": "Quels signes indiquent une infection par le virus de l'herpès ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Les signes incluent des lésions cutanées, des démangeaisons et des douleurs localisées." } }, { "@type": "Question", "name": "Quels symptômes d'une intoxication alimentaire ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent nausées, vomissements, diarrhée et douleurs abdominales." } }, { "@type": "Question", "name": "Comment reconnaître une infection respiratoire ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent toux, fièvre, essoufflement et douleurs thoraciques." } }, { "@type": "Question", "name": "Comment prévenir la dengue en Australasie ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Éliminer les eaux stagnantes et utiliser des répulsifs contre les moustiques." } }, { "@type": "Question", "name": "Quelles mesures pour éviter le chikungunya ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Utiliser des moustiquaires et des répulsifs, et éviter les zones infestées." } }, { "@type": "Question", "name": "Comment se protéger contre le virus Zika ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Éviter les piqûres de moustiques et utiliser des préservatifs lors de rapports sexuels." } }, { "@type": "Question", "name": "Quelles sont les recommandations pour la leptospirose ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Éviter le contact avec des eaux potentiellement contaminées et porter des vêtements de protection." } }, { "@type": "Question", "name": "Comment prévenir les infections respiratoires ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Se laver les mains régulièrement et éviter les contacts avec des personnes malades." } }, { "@type": "Question", "name": "Quels traitements pour la dengue ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement est symptomatique, avec des analgésiques et une hydratation adéquate." } }, { "@type": "Question", "name": "Comment traiter une infection par le virus Zika ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas de traitement spécifique ; le repos et l'hydratation sont recommandés." } }, { "@type": "Question", "name": "Quels médicaments pour le chikungunya ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Les anti-inflammatoires et les analgésiques sont utilisés pour soulager les symptômes." } }, { "@type": "Question", "name": "Comment traiter une infection à leptospirose ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement comprend des antibiotiques et un suivi médical pour éviter les complications." } }, { "@type": "Question", "name": "Quels sont les traitements pour la maladie de Lyme ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Les antibiotiques sont le traitement principal, surtout s'ils sont administrés tôt." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec la dengue ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent la dengue sévère, pouvant entraîner des hémorragies et un choc." } }, { "@type": "Question", "name": "Quels risques associés au chikungunya ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Des douleurs articulaires chroniques peuvent persister longtemps après l'infection." } }, { "@type": "Question", "name": "Quelles complications de l'infection par le virus Zika ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Le virus peut causer des malformations congénitales si contracté pendant la grossesse." } }, { "@type": "Question", "name": "Quelles complications de la leptospirose ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des lésions rénales, hépatiques et des hémorragies pulmonaires." } }, { "@type": "Question", "name": "Quels risques de la maladie de Lyme non traitée ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Les complications peuvent inclure des problèmes neurologiques et des douleurs articulaires chroniques." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque pour la dengue ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent vivre dans des zones tropicales et avoir des antécédents d'infection." } }, { "@type": "Question", "name": "Qui est à risque pour le chikungunya ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Les personnes âgées et celles avec des maladies chroniques sont plus vulnérables." } }, { "@type": "Question", "name": "Quels facteurs augmentent le risque de virus Zika ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Voyager dans des zones endommagées par le virus et être enceinte augmentent le risque." } }, { "@type": "Question", "name": "Quels sont les risques associés à la leptospirose ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Les personnes travaillant en milieu rural ou en contact avec des eaux contaminées sont à risque." } }, { "@type": "Question", "name": "Qui est à risque pour la maladie de Lyme ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Les personnes vivant dans des zones boisées ou ayant des activités de plein air sont à risque." } } ] } ] }

Sources (50 au total)

Contraceptive access and use among women with migratory experience living in high-income countries: a scoping review.

Women who have migrated often encounter difficulties in accessing healthcare and experience inequitable sexual and reproductive health outcomes in destination countries. These health inequities includ... The scientific databases PubMed, Web of Science and CINAHL were searched for peer-reviewed quantitative, qualitative and mixed method articles published between January 2000 and June 2023. Articles we... A total of 68 articles were included, about half (n = 32) from North America. The articles focused on the individual level rather than the health system level, including aspects such as women's contra... There is a lack of knowledge regarding how health systems impose obstacles to contraceptive services for women with migratory experience on an organizational level, as research has focused heavily on ...

Global burden of pelvic inflammatory disease and ectopic pregnancy from 1990 to 2019.

Pelvic inflammatory disease (PID) is a widespread female public problem worldwide. And it could lead to infertility, preterm labor, chronic pelvic pain, and ectopic pregnancy (EP) among reproductive-a... The data of PID and EP among reproductive-aged women (15 to 49 years old) were extracted from the Global Burden of Disease study 2019. The disease burden was assessed by calculating the case numbers a... In 2019, the ASR of PID prevalence was 53.19 per 100,000 population with a decreasing trend from 1990 (EAPC: - 0.50), while the ASR of EP incidence was 342.44 per 100,000 population with a decreasing ... PID and EP continue to be public health burdens with a strong correlation despite slightly decreasing trends detected in ASRs globally. Effective interventions and strategies should be established acc...

Activities critical to success and growth of clinical trials networks. What is needed and how are we doing? An Australian and New Zealand perspective.

Clinical trial evidence underpins evidence-based medicine and the improvement of healthcare worldwide. In Australasia, a significant proportion of clinical trials are conducted by geographically dispe... We conducted surveys and focus groups with Australian and New Zealand CTNs to identifying the activities and attributes that enable CTNs to operate successfully. Based on our findings, we then conduct... Our focus groups identified three key themes associated with success and growth of a CTN: engaged membership, established infrastructure, and sustainability; and thirteen critical success factors: sha... By supporting both emerging and established CTNs to achieve critical success factors, we can improve the efficiency of CTNs to continue to contribute and expand their clinical trial activities. Partic...

Patterns of vitamin D testing and supplementation for children with inflammatory bowel disease in Australasia.

For children with inflammatory bowel disease (IBD), optimal levels of vitamin D are ascribed anti-inflammatory and essential immune system roles that are associated with reduced disease activity, lowe... Members of the Australian Society of Pediatric Gastroenterology, Hepatology and Nutrition were invited to complete an online survey. Respondents were asked to provide information on frequency of vitam... Thirty-two (54%) pediatric gastroenterologists completed the survey: 27 (84%) from Australia and 5 (16%) from New Zealand. The majority (90%) tested vitamin D levels at diagnosis and follow up, althou... The results indicate that standardized guidelines for vitamin D testing and supplementation for clinicians caring for children with IBD throughout Australasia are required. Consensus statements may op...

First Nations populations' perceptions, knowledge, attitudes, beliefs, and myths about prevention and bereavement in stillbirth: a mixed methods systematic review protocol.

The objective of this review is to investigate First Nations populations' perceptions, knowledge, attitudes, beliefs, and myths about stillbirth.... First Nations populations experience disproportionate rates of stillbirth compared with non-First Nations populations. There has been a surge of interventions aimed at reducing stillbirth and providin... The review will consider studies that include individuals of any age (bereaved or non-bereaved) who identify as belonging to First Nations populations. Eligible studies will include the perceptions, k... This review will follow the JBI methodology for convergent mixed methods systematic reviews. The review is supported by an advisory panel of Aboriginal elders, lived-experience stillbirth researchers,... PROSPERO CRD42023379627....